Currenty the second-largest company in Canada in terms of market capitalization behind only Royal Bank of Canada (NYSE: RY ), Valeant is aiming to grow even larger, a task that can be accomplished through acquisitions, according to analysts. A possible takeover candidate for the Canadian pharmaceutical giant is Egyptian company Amoun Pharmaceutical Co. Valeant is also planning an expansion into Asia which could greatly push its growth. Bill Ackman's Pershing Square, and the quant fund D E Shaw are among the top shareholders of Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Disclosure: None